DOTA-Octreotide TFA

SKU: orb2942808

Description

DOTA-Octreotide TFA is a bifunctional conjugate combining the chelator DOTA with the somatostatin analog Octreotide. It is used in cancer research to synthesize radiolabeled conjugates for targeted imaging and therapy, enabling both in vitro receptor binding studies and in vivo preclinical evaluation of somatostatin receptor-positive tumors.

Research Area

Immunology & Inflammation; Pharmacology & Drug Discovery

Key Properties

• MW: 1519.66
• Formula: C₆₇H₉₃F₃N₁₄O₁₉S₂
• SMILES: C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)N[C@H](CO)[C@@H](C)O)O.C(=O)(C(F)(F)F)O

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

172677216